Medical / Pharmaceuticals
Releases published in the last 30 days. 
Page 1 of 2
- Sanofi’s Sarclisa subcutaneous approved in the EU as the first anticancer treatment administered via an on-body injector
- 6/8/2026 10:37:39 AM
- Sanofi’s Sarclisa subcutaneous approved in the EU as the first anticancer treatment administered via an on-body injector • Sarclisa administered via the CirCLIQ ® OBI offers a treatment experience designed around the needs of patients and HCPs and enables flexible administration in either home or outpatient settings • Sarclisa is the first anticancer treatment to …
- Thrifty Food Plan Costs Vary Widely Across US Regions and Cities
- 6/8/2026 9:58:55 AM
- A recent study in the Journal of Nutrition Education and Behavior (JNEB), published by Elsevier, examined how the cost of the USDA’s Thrifty Food Plan (TFP), which serves as the basis for determining maximum SNAP benefits, varied across geographic regions, metropolitan areas, and seasons from 2012 to 2018.
- Can taking aspirin uncover asymptomatic bladder cancer?
- 6/5/2026 9:21:01 AM
- The presence of blood cells in urine is a sign of bladder cancer. Because aspirin blocks platelets from forming harmful blood clots, the medication can cause mild bleeding or worsen existing bleeding in the urinary tract.
- GEODIS to enhance its pharmaceutical logistics capabilities and move into a new temperature controlled, GDP compliant warehouse in Manchester
- 6/4/2026 10:28:06 AM
- GEODIS, a world leader in transport and logistics, announces the opening of a temperature-controlled GDP-compliant pharmaceutical warehouse close to the airport in Manchester designed to support both inventory management and cross-docking operations, reinforcing its capabilities in the fast-growing Pharma & Healthcare sector in the UK and Ireland.
- Sanofi launches 2026 global employee stock purchase plan
- 6/4/2026 10:25:32 AM
- Sanofi’s global employee shareholder plan, Action 2026, opens on June 9, 2026, to around 75,000 employees in 52 countries. Now in its 12th year, the program demonstrates the ongoing commitment of Sanofi and its Board of Directors to involve employees in the company’s growth and results.
- Kaiser Permanente names Emily Holliman president of Mid-Atlantic States region
- 6/3/2026 10:07:22 AM
- Kaiser Permanente has appointed Emily Holliman as president of Kaiser Permanente in the Mid-Atlantic States, effective immediately. Holliman has served as the region’s interim president since June 2025, leading efforts to provide high-quality, integrated health care and coverage to the organization’s 750,551 members across 35 medical centers in Maryland, Virginia, and …
- Johnson & Johnson late-breaking results show nipocalimab significantly reduced systemic lupus erythematosus (SLE) disease activity in a Phase 2 study
- 6/3/2026 10:03:16 AM
- · Nipocalimab – the first and only neonatal Fc receptor (FcRn) blocker to be studied in systemic lupus erythematosus – is designed to target and reduce pathogenic immunoglobulin G (IgG) autoantibodies associated with this disease while preserving immune function · Results demonstrated significant reduction of systemic lupus erythematosus disease activity which continued …
- FDA Issues Draft Guidance to Help Accelerate Cell and Gene Therapies for Patients
- 6/2/2026 10:54:17 AM
- The U.S. Food and Drug Administration (FDA) today issued draft guidance to help developers bring promising gene therapies to patients more efficiently by making greater use of existing scientific and regulatory knowledge.
- Study Links Cannabis and Tobacco Co-Use to Lower Brain Performance in At-Risk Adolescents
- 6/2/2026 10:50:35 AM
- New research shows that among people at clinical high risk for psychosis, cannabis and tobacco co-use was associated with lower cognitive performance compared to healthy controls.
- AMA statement on EO directing CDC to assess childhood vaccine schedule
- 6/1/2026 12:15:33 PM
- Statement attributable to: Bobby Mukkamala, MD President, American Medical Association “There is no credible scientific evidence to support changing the current childhood vaccine schedule.
- WHO launches new guide to help scale psychological self-help
- 6/1/2026 12:00:08 PM
- Psychological self-help interventions: delivering self-help for individuals, featuring Step-by-Step and Doing What Matters in Times of Stress provides practical advice on planning, adapting and delivering self-help, with or without support from trained non-specialists.
- Dr. Ashish Jha Headlines ConV2X Smart Technology Transformation Summit - NYC Oct 2026
- 6/1/2026 8:00:00 AM
- Partners in Digital Health today announced that Dr. Ashish Jha, one of the most influential voices in modern healthcare policy and public health leadership, will headline ConV2X Smart Technology Transformation in Healthcare & Life Sciences, taking place October 29–30, 2026, at the Historic GE Building: ILR Conference Center in New York City.
- CONV2X Decentralized Health & Life Science Summit Releases FIRST SPEAKER COHORT
- 6/1/2026 8:00:00 AM
- Partners in Digital Health is proud to announce the first speaker cohort for ConV2X Decentralized Health — a landmark gathering of innovators, clinicians, technologists, and policy leaders reimagining the future of healthcare through decentralized infrastructure.
- 1 in 3 Women Don’t Know Menopause and Bone Loss Are Connected, New Osteoboost Data Reveals
- 5/28/2026 12:00:00 PM
- Disney and Philips Bring Beloved Storytelling and Innovative Technology to Support Kids Undergoing MRI Exams
- 5/28/2026 11:43:22 AM
- The Walt Disney Company and Philips today announced that beloved Disney animated characters and stories are being incorporated directly into Philips Ambient Experience for MRI at medical facilities in 87 countries worldwide.
- Scars of Life: Study Shows Impact of Atopic Dermatitis on Educational and Career Choices
- 5/28/2026 11:32:40 AM
- Atopic dermatitis (AD), the most common form of eczema, impacts patients’ life trajectories beyond the physical scars. A novel study shows that adults with AD, particularly those with childhood onset, report significantly greater limitations in their educational and professional choices, with up to 38% of childhood-onset patients reporting career restrictions and more than …
- Sanofi’s venglustat accepted for priority review in the US to treat type 3 Gaucher disease
- 5/28/2026 9:37:11 AM
- The US Food and Drug Administration (FDA) has granted priority review to the new drug application (NDA) for venglustat, a novel, investigational oral glucosylceramide synthase inhibitor (GCSi), for the treatment of type 3 Gaucher disease (GD3), a rare lysosomal storage disorder.
- MindMaze Therapeutics Chooses Connect Labs by Wexford at Charlotte’s The Pearl Innovation District for U.S. Headquarters to Advance Neurological Care
- 5/28/2026 9:00:00 AM
- MindMaze Therapeutics, a pioneer in precision neurotherapeutics, has announced a U.S headquarters at The Pearl, Charlotte’s Innovation District, a partnership between Atrium Health and Wexford Science & Technology, LLC.
- Wiley Bolsters Research Integrity Efforts with Imagetwin’s Enhanced Image Screening
- 5/26/2026 10:00:47 AM
- Wiley (NYSE: WLY), a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation and learning, today announced that it has integrated Imagetwin’s leading AI-powered image integrity software into Research Exchange, its award-winning research publishing platform.
- Shofu, Tosoh, Mitsui Chemicals, and Orbray Launch Joint Project to Recycle Zirconia Dental Waste
- 5/22/2026 12:20:28 PM
- Shofu Inc. (headquartered in Kyoto, Kyoto Prefecture; Tetsuo Takami, Representative Director, President & COO); Tosoh Corporation (headquartered in Chuo-ku, Tokyo; Mamoru Kuwada, president and representative director); Mitsui Chemicals, Inc.